Evidence map›Paper›PMID 39176284›Full record

ReviewFrontiers in microbiology2024

Exploring the use of microbial enhanced oil recovery in Kazakhstan: a review.

Aliya Yernazarova, Ulzhan Shaimerdenova, Nuraly Akimbekov, Gulzhan Kaiyrmanova, Muhtar Shaken, Asem Izmailova

Abstract readReview
In one paragraph

Review in Frontiers in microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aliya YernazarovaFaculty of Biology and Biotechnology, Al-Farabi Kazakh National University, Almaty, Kazakhstan.
Ulzhan ShaimerdenovaFaculty of Biology and Biotechnology, Al-Farabi Kazakh National University, Almaty, Kazakhstan.
Nuraly AkimbekovFaculty of Biology and Biotechnology, Al-Farabi Kazakh National University, Almaty, Kazakhstan.
Gulzhan KaiyrmanovaFaculty of Biology and Biotechnology, Al-Farabi Kazakh National University, Almaty, Kazakhstan.
Muhtar ShakenKMG Engineering LLP, Astana, Kazakhstan.
Asem IzmailovaKMG Engineering LLP, Astana, Kazakhstan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microbial enhanced oil recovery (MEOR) is a promising method for improving oil recovery from challenging reservoirs such as those found in Kazakhstan. MEOR relies on the activities of microorganisms to modify the properties of the reservoir, such as reducing the oil viscosity, increasing the reservoir permeability, and generating by-products that mobilize the oil. Implementing MEOR in Kazakhstan could lead to significant economic benefits for the country by increasing oil production and royalties from fossil fuel exports. Oil production in Kazakhstan has seen fluctuations in recent years, with 2018 recording a production level of 1.814 million barrels per day. Among regions, Atyrau region contributed the most to oil production with 23.4 million tons of oil. Following Atyrau, the Mangystau region produced 8.2 million tons, and Aktobe produced 2.4 million tons. Overall, the use of MEOR in Kazakhstan's oil fields could offer a promising solution for enhanced oil recovery, while minimizing environmental impact and cost. While specific data on the current use of MEOR in field conditions in Kazakhstan might be limited, the fact that studies are underway suggests a growing interest in applying this technology in the country's oil fields. It is exciting to think about the potential benefits these studies could bring to Kazakhstan's oil industry once their findings are implemented in field operations. These studies have significant implications for Kazakhstan's oil production in the future.

Indexed as

crude oilmicrobial enhanced oil recoverymicroorganismsoil productiontertiary oil recovery

Identifiers

PMID39176284
PMCPMC11340538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.